Edwards Lifesciences (BSP:E1WL34) Total Equity : R$35,787 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Edwards Lifesciences Total Equity?

Edwards Lifesciences's total equity for the quarter that ended in Mar. 2024 was R$35,787 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Edwards Lifesciences Total Equity Historical Data

The historical data trend for Edwards Lifesciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Total Equity Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

17,026.70

23,533.40

33,001.43

30,458.46

32,923.72

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Equity	Get a 7-Day Free Trial															31,574.53	31,289.38	33,223.13	32,923.72	35,786.84

Edwards Lifesciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Edwards Lifesciences's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	45877.807	-	12954.091
	=	32,924

Edwards Lifesciences's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2024 )	-	Total Liabilities(Q: Mar. 2024 )
	=	48484.827	-	12697.992
	=	35,787

Edwards Lifesciences Total Equity Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (BSP:E1WL34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (BSP:E1WL34) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany EWLS:Austria

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (BSP:E1WL34) Headlines

No Headlines